Share Name Share Symbol Market Type Share ISIN Share Description
AstraZeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -11.00p -0.23% 4,763.00p 4,763.00p 4,764.00p 4,787.00p 4,742.50p 4,772.50p 608,602 13:46:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 18,627.4 2,876.5 224.3 23.2 60,282.46

AstraZeneca Share Discussion Threads

Showing 10426 to 10447 of 10450 messages
Chat Pages: 418  417  416  415  414  413  412  411  410  409  408  407  Older
DateSubjectAuthorDiscuss
18/9/2017
11:43
I think its GS had a negative note on Astra.
montyhedge
17/9/2017
19:26
buywell FTSE 100 alert issued 7100 coming next week followed by 6750 within 4 weeks as of today Reasons why posted on BARC AZN chart IMO like that of BARC in now starting another leg down as it is on every chart I have looked at this evening BARC ,RBS ,LLOY ,BP. , SIA , GNK and now AZN FTSE 100 at 6750 should equate to a retest of 4380p AZN IMO $29 in the US dyor
buywell3
07/9/2017
19:21
Heading towards the very big gap
holts
07/9/2017
11:56
the new asthma drug looks promising.
careful
03/9/2017
17:53
can expect a pullback from a chart point of view, if current pattern is to be continued, North Korea likely to influence markets tomorrow, expecting 4480 to give support, but external factors can blow any charts out the window
nocky44
03/9/2017
09:13
Alp - Don't always agree with you but that post is bang on the money.
ianood
02/9/2017
11:59
Nothing new here. IP has always been an issue. Generics will nearly always appear once big sellers go off patent. The strength of the IP protection has always been important. No lessons to be learnt.
alphorn
01/9/2017
12:29
Re GSK or AZN Why not try both?
marksp2011
11/8/2017
10:48
Hmm. This is the first post of the trading week and I have nothing to say.
grahamite2
05/8/2017
07:32
Neurological diseases like Alzheimers' are being wrongly diagnosed They are forms of CJD caused by prions ..... it is a MASSIVE cover up read this hTTps://www.thetyee.ca/Documents/2017/06/24/Risk-Advisory-Opinion-CWD-2017.pdf then this hTTp://crossbowcommunications.com/wildlife-contracting-brain-disease-from-biosolids/
buywell3
02/8/2017
15:00
M, would be interesting. GSK X for 19 pence tomorrow from memory. Agree with Woodford's comment on liberal amounts of full valuations currently. I'm often too cautious though. Edit, GSK XD is next Thursday.
essentialinvestor
02/8/2017
14:03
Happy to compare notes in 12-18mnths romeike Your GSK against my RB. and AZN equivalent mix.
minerve
02/8/2017
13:41
Rubbish, there is only one reason to hold AZ now over GSK and that is on the hope it will get bought out. May government will never see AZ sold off, just look at recent statements on this exact point. Current CEO should be begging investors for forgiveness for poo-pooing an AMAZING offer from Pfizer, shamelessly hyping AZ pipeline into the stratosphere. On the other hand, having seen Emma Walmsley at GSK in action, very impressive... If I want risk I'll go biotech thanks, better returns than anything AZ offers. Good luck all.
romeike
02/8/2017
08:14
GSK have got work to do on the medium term pipeline, their advantage, for now, is having ample time for development with no major patent loses until 2026/7. AZN as a pure pharma play is higher risk/higher reward imv.
essentialinvestor
01/8/2017
23:09
AZN all the way. Easy options deliver mediocre performance. Stick with your GSK, get your slippers and cocoa and enjoy the silence....
minerve
01/8/2017
19:23
GSK has no imminent patent cliff Heading towards a wall is not trueAZ has sold all the family silver to fund new drugs that may or may not deliver - take your pick
mattboxy
01/8/2017
14:48
"GSK is heading towards a brick wall" If that ISN'T the case then why the sudden desperate move to invest in pharma?
minerve
01/8/2017
13:31
"GSK is heading towards a brick wall" - What trash. GSK is growing, AZN not so much.
romeike
31/7/2017
15:48
Astra is the one again on bid list plenty of upside
nw99
31/7/2017
15:20
"Think Woodford sold the wrong Big Pharma. Beware the dead cat bounce. Soriot gone by Christmas." No. Definetely not. GSK is heading towards a brick wall.
minerve
31/7/2017
14:59
Think Woodford sold the wrong Big Pharma. Beware the dead cat bounce. Soriot gone by Christmas.
romeike
30/7/2017
19:12
Finally, Sabah Meddings, writing for Sunday Times' 'Inside The City' column, looked at AstraZeneca, with a share price that plunged last week after it revealed its key 'Mystic' cancer drug trial had produced disappointing results.The drugmaker had tried its best to deflect the bad news by highlighting ann $8.5bn partnership with Merck over its Lynparza cancer treatment, as well as positive phase III results for another of its cancer candidates Tagrisso.But investors were having none of it, wiping £10bn off the value of AstraZeneca in a single day.Meddings suggested the City may have overreacted, however, saying the crash could have been exacerbated by uncertainty over the future of the company's chief Pascal Soriot, and pointing out Neil Woodford's decision to continue to back Astra over rival GlaxoSmithKline.Woodford had noted that Astra remained "very attractive" - comments backed up by Citi's 'buy' rating on the stock.Meddings said Astra's shares looked cheap compared to GSK at 22 times earnings - about half of Glaxo's valuation - but added that Astra's value wasn't wildly different to the rest of the sector globally.She said that - Mystic aside - the results were "OK", as revenue fell 11% to $10.5bn in the first half, in line with expectations, and profits still leaping 22% to $1.8bn even after accounting for weak sterling.Meddings said it would take time for other projects to emerge from the lab in an investable state, although ongoing speculation of a potential bid from Novartis would likely "keep a floor" on Astra's price."Therefore, Astra looks like a reasonable each-way bet - and one that pays a dividend."
nw99
Chat Pages: 418  417  416  415  414  413  412  411  410  409  408  407  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170920 13:01:28